Form 4 · Filed Jun 18, 2026, 09:23 PM UTC
CRNX/Crinetics Pharmaceuticals, Inc.
Okey Stephanie — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | S | sell | 6,292 | $36 | $224,121 | 7,008 |
| Jun 17, 2026 | S | sell | 608 | $36 | $22,022 | 6,400 |
Source: SEC EDGAR raw filing ↗ · Accession 0001628280-26-044419